A randomized controlled trial of financial incentives for smoking cessation

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 1, 2006, Pages 12-18

  Volpp, Kevin G ^a,b,c,g   Levy, Andrea Gurmankin ^e,f   Asch, David A ^a,b,c   Berlin, Jesse A ^c   Murphy, John J ^a   Gomez, Angela ^a   Sox, Harold ^c   Zhu, Jingsan ^a   Lerman, Caryn ^c,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; NICOTINE;

ADULT; ARTICLE; BEHAVIOR MODIFICATION; CHRONIC DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FINANCE; FOLLOW UP; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTIVATION; PATIENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAXATION TRAINING; SELF REPORT; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT OUTCOME; UNITED STATES; URINE LEVEL; ECONOMICS; HEALTH PROMOTION; METHODOLOGY; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; REWARD; SOCIAL CLASS; URINE;

COTININE; FEMALE; FOLLOW-UP STUDIES; HEALTH PROMOTION; HUMANS; MALE; MIDDLE AGED; MOTIVATION; PATIENT COMPLIANCE; REWARD; SMOKING CESSATION; SOCIAL CLASS;

EID: 33645458033     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0314     Document Type: Article

References (41)

1. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA 2004;291:1238-45.
2. Pagan P, King G, Lawrence D, et al. Eliminating tobacco-related health disparities: directions for future research. Am J Public Health 2004;94:211-7.
3. Hjalmarson A, Franzon M, Westin A, Wiklund O. Effect of nicotine nasal spray on smoking cessation. A randomized, placebo-controlled, double-blinded study. Arch Intern Med 1994;154:2567-72.
4. Eddy DM. David Eddy ranks the tests. Harv Health Lett 1992;(July suppl):10-11.
5. Cromwell J, Bartosch WJ, Fiore MC, Hasselblad V, Baker T. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. JAMA 1997;278:1759-66.
6. Coffield AB, Maciosek MV, McGinnis JM, et al. Priorities among recommended clinical preventive services. Am J Prev Med 2001;21:1-9.
7. Zhu S, Melcer T, Sun J, Rosbrook B, Pierce JP. Smoking cessation with and without assistance: a population-based analysis. Am J Prev Med 2000;18:305-11.
8. Bartlett J, Miller L, Rice D, Max W. Medical care expenditures attributable to cigarette smoking: United States, 1993. MMWR Morb Mortal Wkly Rep 1994;43:469-72.
9. Hughes JR. Motivating and helping smokers to stop smoking. J Gen Intern Med 2003;18:1053-7.
10. Higgins ST, Silverman K, editors. Motivating behavior change among illicit drug abusers: research on contingency management interventions. Washington (DC): American Psychological Association; 1999.
11. Higgins ST. Applying behavioral economics to the challenge of reducing cocaine abuse. In: Chaloupka F, Grossman M, Bickel WK, Saffer H, editors. The economic analysis of substance use and abuse. Chicago: University of Chicago Press; 1999. p. 157-74.
12. Petry NM, Simcic F. Recent advances in the dissemination of contingency management techniques: clinical and research perspectives. J Subst Abuse Treat 2002;23:81-6.
13. Shoptaw S, Rotheram-Fuller E, Yang X, et al. Smoking cessation in methadone maintenance. Addiction 2002;97:1317-2.
14. Marcus A, Kaplan CP, Crane LA, Berek JS, Bernstein G, Gunning JE. Reducing loss to follow-up among women with abnormal pap smears: Results from a randomized trial testing an intensive follow-up protocol and economic incentives. Med Care 1998;36:397.
15. Hennrikus DJ, Jeffery RW, Lando HA, et al. The SUCCESS project: the effect of program format and incentives on participation and cessation in worksite smoking cessation programs. Am J Public Health 2002;92:274-9.
16. Donatelle RJ, Prows SL, Champeau D, Hudson D. Randomised controlled trial using social support and financial incentives for high risk pregnant smokers: Significant Other Supporter (SOS) program. Tob Control 2000;9:11167-9.
17. Bain N, Pickett W, Hoey J. The use and impact of incentives in population-based smoking cessation programs: a review. Am J Health Promot 1998;12:307-20.
18. Donatelle RJ, Hudson D, Dobie S, Goodall A, Hunsberger M, Oswald K. Incentives in smoking cessation: status of the field and implications for research and practice with pregnant smokers. Nicotine Tob Res 2004;9:S163-79.
19. Curry SJ, Wagner EH, Grothaus LC. Evaluation of intrinsic and extrinsic motivation interventions with a self-help smoking cessation program. J Consult Clin Psychol 1991;59:318-24.
20. Hawkins L. As GM battles surging costs, workers' health becomes issue. The Wall Street Journal. 2005 April 7; sect. A:1.
21. Hakim D, Peters JW. Shares of GM tumble on issue of health care. The New York Times. 2005 April 15; sect. C:4.
22. Hymowitz N, Cummings KM, Hyland A, Lynn WR, Pechacek TF, Hartwell TD. Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tob Control 1997;6 Suppl 2:557-62.
23. U.S. Department of Health and Human Services. The health benefits of smoking cessation. Atlanta, Georgia: Centers for Disease Control and Prevention, National Center on Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1990.
24. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002;4:149-59.
25. Cummings SR, Richard RJ. Optimum cutoff points for biochemical validation of smoking status. Am J Public Health 1988;78:574-5.
26. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measure of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003;5:13-25.
27. Heatherton TF, Kozlowki LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict 1991;86:1119-27.
28. Westman EC, Behm FM, Simel DL, Rose JE. Smoking behavior on the first day of a quit attempt predicts long-term abstinence. Arch Intern Med 1997;157:335-40.
29. Curry S, Wagner EH, Grothaus LC. Intrinsic and extrinsic motivation for smoking cessation. J Consult Clin Psychol 1990;58:310-6.
30. Centers for Disease Control and Prevention. Smoking cessation during previous year among adults - United States, 1990 and 1991. MMWR Morb Mortal Wkly Rep 1993;42:504-7.
31. MacKenzie TD, Pereira RI, Mehler PS. Smoking abstinence after hospitalization: predictors of success. Prev Med 2004;39:1087-92.
32. Hymowitz N, Cummings KM, Hyland A, Lynn WR, Pechacek TF, Hartwell TD. Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tob Control 1997;6 Suppl 2:557-62.
33. Hymowitz N, Sexton M, Ockene J, Grandits G. Baseline factors associated with smoking cessation and relapse. Prev Med 1991;19:590-601.
34. Wong MD, Shapiro MF, Boscardin WJ, Ettner SL. Contribution of major diseases to disparities in mortality. N Engl J Med 2002;347:1585-92.
35. Curry SJ, Grothaus LC, McAfee T, Pabiniak C. Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization. N Engl J Med 1998;339:673-9.
36. Pauly MV, Held PJ. Benign moral hazard and the cost-effectiveness analysis of insurance coverage. J Health Econ 1990;9:447-61.
37. Centers for Disease Control and Prevention (CDC). Annual smoking-attributable mortality, years of potential life lost, and economic costs - United States, 1995-1999. MMWR Morb Mortal Wkly Rep 2002;51:300-3.
38. Matson DM, Lee JW, Hopp JW. The impact of incentives and competitions on participation and quit rates in worksite smoking cessation programs. Am J Health Promot 1993;7:270-80, 295.
39. Klesges RC, Cirgang JA. Worksite smoking cessation programs: clinical and methodological issues. Progress in Behavior Modification 1988;23:36-61.
40. Ware JH. Interpreting incomplete data in studies of diet and weight loss. N Engl J Med 2003;348:2136-7.
41. Hall SM, Delucchi KL, Velicer WF, et al. Statistical analysis of randomized trials in tobacco treatment: longitudinal designs with dichotomous outcome. Nicotine Tob Res 2001;3:193-202.